Trials / Completed
CompletedNCT04025333
Helping Ethnic Minority in Hong Kong to Quit Smoking by Understanding Their Knowledge, Attitude and Behavior Related to Smoking
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- The University of Hong Kong · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims at understanding the needs and concerns of the ethnic minority in Hong Kong, including their behavior, attitudes, and experiences related to smoking and smoking cessation. Specifically, how the level of smoking-related knowledge among them differ from the rest of the Hong Kong people, will be explored. In addition, whether Hong Kong smoking policy influenced the smoking pattern of them will be investigated.
Detailed description
Cigarette smoking is the most significant preventable cause of death and disease, causing 6 million deaths annually worldwide. Despite the fact that tobacco use in Hong Kong has been decreased from 23.3% in 1982 to 10.1% in 2017, the remaining 620 600 daily smokers\[3\] cannot be overlooked or undervalued. Hong Kong is a predominantly Chinese society, but it has a sizeable South Asian ethnic minority (EM). According to the Census \& Statistics Department, the number of ethnic minorities in Hong Kong increased significantly by 70.8% over the past 10 years. Nevertheless, few smoking and health promotion activities and smoking cessation services have been tailor-made for ethnic minorities in Hong Kong. The barrier of supplying smoking cessation service to the ethnic minority group is that their smoking motivation, willingness to quit, obstacles of quit smoking, attitude towards Hong Kong tobacco law and smoking cessation services are not sure. This will be the first research exploring their knowledge, attitude and experience of cigarette smoking.
Conditions
Timeline
- Start date
- 2018-09-18
- Primary completion
- 2019-04-18
- Completion
- 2019-08-31
- First posted
- 2019-07-18
- Last updated
- 2020-04-21
Locations
1 site across 1 country: Hong Kong
Source: ClinicalTrials.gov record NCT04025333. Inclusion in this directory is not an endorsement.